# Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

> **NCT03851445** · PHASE2,PHASE3 · RECRUITING · sponsor: **SWOG Cancer Research Network** · enrollment: 10000 (estimated)

## Conditions studied

- Previously Treated Non-Small Cell Lung Cancer

## Interventions

- **DRUG:** Screening Platform

## Key facts

- **NCT ID:** NCT03851445
- **Lead sponsor:** SWOG Cancer Research Network
- **Sponsor class:** NETWORK
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-02-06
- **Primary completion:** 2029-01-28
- **Final completion:** 2029-01-28
- **Target enrollment:** 10000 (ESTIMATED)
- **Last updated:** 2026-05-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03851445

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03851445, "Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03851445. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*